NewAmsterdam Pharma ...
NasdaqGM:NAMS
$ 30,38
$-0,57 (-1,84%)
30,38 $
$-0,57 (-1,84%)
End-of-day quote: 06/09/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-1,71
Earnings Per Share
$0,19
Revenue Per Share
0,00%
Operating Margin %
$3,55 B
Market Cap
$0,00 B
Long-Term Debt
Earnings Per Share
$-1,71
Revenue Per Share
$0,19
Operating Margin %
0,00%
Market Cap
$3,55 B
Long-Term Debt
$0,00 B

Financials

Year Year 2025 2024 2023
EPS Earnings Per Share $-1,71 $-2,52 $-1,98
Earnings Earnings $-196,62M $-276,75M $-176,75M
RPS Revenue Per Share $0,19 $0,41 $0,15
Revenue Revenue $22,34M $44,93M $13,01M
OCF Operating Cash Flow $-146,85M $-156,22M $-130,34M
FCF Free Cash Flow $-127,97M $-156,88M $0,00M
OM Operating Margin 0,00% 0,00% 0,00%
GM % Gross Margin % 100,00% 100,00% 100,00%
FCFS Free Cash Flow Per Share $-1,25 $-1,69 $-1,72
LT Debt Long-Term Debt N/A N/A N/A
Sha. Stocks 114,98M 109,82M 89,27M
×